BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22127700)

  • 1. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe.
    Ryu JH; Lee A; Chu JU; Koo H; Ko CY; Kim HS; Yoon SY; Kim BS; Choi K; Kwon IC; Kim K; Youn I
    Arthritis Rheum; 2011 Dec; 63(12):3824-32. PubMed ID: 22127700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of active matrix metalloproteinase-3 in serum and fibroblast-like synoviocytes of collagen-induced arthritis mice.
    Lee A; Choi SJ; Park K; Park JW; Kim K; Choi K; Yoon SY; Youn I
    Bioconjug Chem; 2013 Jun; 24(6):1068-74. PubMed ID: 23706153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response.
    Wunder A; Tung CH; Müller-Ladner U; Weissleder R; Mahmood U
    Arthritis Rheum; 2004 Aug; 50(8):2459-65. PubMed ID: 15334458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of antiarthritic drug efficacies by monitoring active matrix metalloproteinase-3 (MMP-3) levels in collagen-induced arthritic mice using the MMP-3 probe.
    Lee A; Park K; Choi SJ; Seo DH; Kim K; Kim HS; Choi K; Kwon IC; Yoon SY; Youn I
    Mol Pharm; 2014 May; 11(5):1450-8. PubMed ID: 24673659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis.
    Beehler BC; Hei YJ; Chen S; Lupisella JA; Ostrowski J; Starrett JE; Tortolani D; Tramposch KM; Reczek PR
    J Rheumatol; 2003 Feb; 30(2):355-63. PubMed ID: 12563696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo.
    Lee S; Park K; Lee SY; Ryu JH; Park JW; Ahn HJ; Kwon IC; Youn IC; Kim K; Choi K
    Bioconjug Chem; 2008 Sep; 19(9):1743-7. PubMed ID: 18729392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "One-step" detection of matrix metalloproteinase activity using a fluorogenic peptide probe-immobilized diagnostic kit.
    Ryu JH; Lee A; Lee S; Ahn CH; Park JW; Leary JF; Park S; Kim K; Kwon IC; Youn IC; Choi K
    Bioconjug Chem; 2010 Jul; 21(7):1378-84. PubMed ID: 20575580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of near-infrared fluorescence imaging using a polymeric nanoparticle-based probe for the diagnosis and therapeutic monitoring of colon cancer.
    Yoon SM; Myung SJ; Kim IW; Do EJ; Ye BD; Ryu JH; Park K; Kim K; Kwon IC; Kim MJ; Moon DH; Yang DH; Kim KJ; Byeon JS; Yang SK; Kim JH
    Dig Dis Sci; 2011 Oct; 56(10):3005-13. PubMed ID: 21465144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of experimental arthritis with near-infrared fluorescence.
    Hansch A; Frey O; Sauner D; Hilger I; Haas M; Malich A; Bräuer R; Kaiser WA
    Arthritis Rheum; 2004 Mar; 50(3):961-7. PubMed ID: 15022340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
    Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
    Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and mechanisms of total glucosides of paeony on joint damage in rat collagen-induced arthritis.
    Zhu L; Wei W; Zheng YQ; Jia XY
    Inflamm Res; 2005 May; 54(5):211-20. PubMed ID: 15953993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
    Chen J; Zhang XM; Xu Q
    Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
    Lee SW; Kim JH; Park MC; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(4):260-8. PubMed ID: 18612926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis.
    Galligan CL; Fish EN
    Arthritis Rheum; 2012 Nov; 64(11):3583-93. PubMed ID: 22729466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
    Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
    Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.